Since TMB, MSI, DNMT and MMR expression were proved associated with the efficiency of checkpoint-blocked therapy across various cancer types, the relationships between CD274/PDCD1LG2 and these markers were examined (Supplementary Table S4, S5). The gene discussed is DNMT1; the disease is cancer.